142 related articles for article (PubMed ID: 37975600)
1. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
Chandar AK; Keerthy K; Gupta R; Grady WM; Canto MI; Shaheen NJ; Thota PN; Iyer PG; Wang JS; Falk GW; Abrams JA; Dumot J; Faulx A; Markowitz SD; Willis J; Moinova H; Guda K; Brock W; Chak A
Am J Gastroenterol; 2024 May; 119(5):823-829. PubMed ID: 37975600
[TBL] [Abstract][Full Text] [Related]
2. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
3. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
5. Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.
Rubenstein JH; Scheiman JM; Sadeghi S; Whiteman D; Inadomi JM
Am J Gastroenterol; 2011 Feb; 106(2):254-60. PubMed ID: 21139576
[TBL] [Abstract][Full Text] [Related]
6. Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population.
Bakr O; Zhao W; Corley D
J Clin Gastroenterol; 2018; 52(10):873-879. PubMed ID: 29356784
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of young patients with early Barrett's neoplasia.
Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
[TBL] [Abstract][Full Text] [Related]
8. Gender difference in gastro-esophageal reflux diseases.
Asanuma K; Iijima K; Shimosegawa T
World J Gastroenterol; 2016 Feb; 22(5):1800-10. PubMed ID: 26855539
[TBL] [Abstract][Full Text] [Related]
9. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis.
Nason KS; Wichienkuer PP; Awais O; Schuchert MJ; Luketich JD; O'Rourke RW; Hunter JG; Morris CD; Jobe BA
Arch Surg; 2011 Jul; 146(7):851-8. PubMed ID: 21768433
[TBL] [Abstract][Full Text] [Related]
10. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal Reflux Disease Is Not a Great Screening Criterion: Time to Move on to Other Strategies for Controlling the Burden of Esophageal Adenocarcinoma.
Rubenstein JH
Am J Gastroenterol; 2022 Nov; 117(11):1759-1761. PubMed ID: 36327434
[TBL] [Abstract][Full Text] [Related]
12. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.
Hammad TA; Thrift AP; El-Serag HB; Husain NS
Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493
[TBL] [Abstract][Full Text] [Related]
13. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma.
Sawas T; Zamani SA; Killcoyne S; Dullea A; Wang KK; Iyer PG; Fitzgerald RC; Katzka DA
Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1709-1718. PubMed ID: 34757196
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
15. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction.
Rubenstein JH; Raghunathan T; Doan C; Schneider J; Zhao W; Metko V; Nofz K; Khodadost M; Corley DA
Am J Gastroenterol; 2021 May; 116(5):949-957. PubMed ID: 33852454
[TBL] [Abstract][Full Text] [Related]
16. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
[TBL] [Abstract][Full Text] [Related]
17. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
18. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany.
Schmidt M; Ankerst DP; Chen Y; Wiethaler M; Slotta-Huspenina J; Becker KF; Horstmann J; Kohlmayer F; Lehmann A; Linkohr B; Strauch K; Schmid RM; Quante AS; Quante M
Cancer Prev Res (Phila); 2020 Apr; 13(4):377-384. PubMed ID: 32066580
[TBL] [Abstract][Full Text] [Related]
20. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia.
Chak A; Faulx A; Eng C; Grady W; Kinnard M; Ochs-Balcom H; Falk G
Cancer; 2006 Nov; 107(9):2160-6. PubMed ID: 17019737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]